CN EN

Cure Insomnia

Improve Anxiety and Insomnia

Scroll

Cytocraft III Cells

A Viable Technique for Improving Manic Depression

Activating Factors, Improving Manic Depression, Anxiety and Insomnia

In response to nervous system sub-health, the T cells activated by special pathways (Cytocraft-3 cells) can secrete a large number of nerve factors, such as NGF, NT3/NT4, BDNF, and these nerve factors can promote the recovery of nervous system. In addition, Cytocraft-3 cells contain neurotransmitter receptors similar to nerve cells, which can regulate nerve function. According to the clinical trial treatments performed at the Immunotherapy Research Center in Munich, Germany, Cytocraft-3 cells can improve the symptoms of manic depression, and can also improve general sub-health status, such as anxiety and insomnia.

The History of Research on Cytocraft III Cells for Improving the Symptoms of Manic Depression

  • In 1999, it was first discovered that Th1/Th2-polarized T lymphocytes can secrete neuronal factors and nerve growth factors.

  • In 2002, it was proposed that mental disorders need long-term immunotherapy.

  • In 2005, activated immune cells (Cytocraft-3 cells) were used for the treatment of manic depression, and the treatment was successful.

  • In 2011, it was proposed that mental disorders are associated with long-term subclinical infection of chlamydia.

  • In 2013, the Cytocraft-3 cell technique was invented

  • In 2013, it was discovered that mental disorders are associated with the abnormal regulation of lymphocyte factor (interferon gamma) after infection.

  • In 2017, activated immune cells (Cytocraft-3 cells) were used to awaken patients in a long-term vegetative state, and the treatment was successful.

  • In 2017, activated immune cells (Cytocraft-3 cells) were used to treat Alzheimer's disease, and the treatment was successful.

2019©LifeBank Biotech Co., Ltd.

Powered by SE